LO Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine umfassende Sammlung von LO-Antikörpern für den Nachweis und die Analyse von Lipoxygenase (LO)-Proteinen. LO-Antikörper sind kompatibel mit Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffin eingebetteten Schnitten (IHCP), Durchflusszytometrie (FCM) und Enzyme-Linked Immunosorbent Assay (ELISA). Lipoxygenasen spielen eine entscheidende Rolle im Arachidonsäurestoffwechsel, der zur Produktion von Leukotrienen und anderen bioaktiven Lipiden führt, die an Entzündungsreaktionen und Zellsignalen beteiligt sind. Das Verständnis der Funktion von Lipoxygenasen ist wichtig, um ihren Beitrag zu verschiedenen physiologischen und pathologischen Prozessen wie Asthma, Herz-Kreislauf-Erkrankungen und Krebs aufzudecken. Die monoklonalen LO-Antikörper ermöglichen den präzisen Nachweis und die Charakterisierung von Lipoxygenase-Expressionsmustern in verschiedenen Gewebetypen. Forscher können die Lipoxygenase-Aktivität unter verschiedenen experimentellen Bedingungen und in Krankheitsmodellen effektiv verfolgen. Fortschrittliche Visualisierungstechniken mit fluoreszierenden Konjugaten wie Meerrettichperoxidase (HRP), Phycoerythrin (PE) und Fluoresceinisothiocyanat (FITC) liefern klare und spezifische Signale. Die monoklonalen Antikörper von Santa Cruz Biotechnology für die Lipoxygenase-Forschung unterstützen Wissenschaftler weltweit dabei, unser Verständnis von Entzündungskrankheiten zu verbessern und potenzielle therapeutische Strategien zu entwickeln.
LO Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
5-LO Antikörper (33) | sc-136195 | mouse IgG1 κ | 442-590 (h) | WB, IP, IF | m, r, h | 18 | ||
5-LO Antikörper (B-3) | sc-518174 | mouse IgG2a κ | 106-225 (h) | WB, IP, IF, IHC(P), ELISA | h | neu | ||
5-LO Antikörper (A-9) | sc-518175 | mouse IgG1 κ | 106-225 (h) | WB, IP, IF, IHC(P), ELISA | h | neu | ||
12-LO Antikörper (C-5) | sc-365194 | mouse IgG1 κ | 131-230 (h) | WB, IP, IF, ELISA | m, r, h | 21 | ||
15-LO Antikörper (B-7) | sc-133085 | mouse IgG1 κ | C-Terminal (h) | WB, IP, IF, ELISA | m, r, h | 22 | ||
15-LO2 Antikörper (D-9) | sc-271290 | mouse IgG1 κ | 423-452 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 7 | ||
15-LO2 Antikörper (F-10) | sc-376795 | mouse IgG1 κ | 36-85 (m) | WB, IP, IF, ELISA | m, r, h | 1 | ||
15-LO2 Antikörper (D-6) | sc-376871 | mouse IgG1 κ | 146-200 (h) | WB, IP, IF, ELISA | h | 1 | ||
15-LO2 Antikörper (H-6) | sc-166387 | mouse IgG2b κ | 423-452 (h) | WB, IP, IF, ELISA | h | 1 |
LO CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
5-LO CRISPR/Cas9 KO Plasmid (h) | sc-401239 | h | Gene Knockout | GFP | 0 | ||
5-LO CRISPR/Cas9 KO Plasmid (h2) | sc-401239-KO-2 | h | Gene Knockout | GFP | 0 | ||
5-LO HDR Plasmid (h2) | sc-401239-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
5-LO Double Nickase Plasmid (h) | sc-401239-NIC | h | Gene Knockout | Puromycin | 0 | ||
5-LO Double Nickase Plasmid (h2) | sc-401239-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
5-LO CRISPR/Cas9 KO Plasmid (m) | sc-419091 | m | Gene Knockout | GFP | 0 | ||
5-LO Double Nickase Plasmid (m) | sc-419091-NIC | m | Gene Knockout | Puromycin | 0 | ||
5-LO Double Nickase Plasmid (m2) | sc-419091-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
12-LO CRISPR/Cas9 KO Plasmid (h) | sc-403010 | h | Gene Knockout | GFP | 1 | ||
12-LO HDR Plasmid (h) | sc-403010-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
12-LO Double Nickase Plasmid (h) | sc-403010-NIC | h | Gene Knockout | Puromycin | 1 | ||
12-LO Double Nickase Plasmid (h2) | sc-403010-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
12-LO CRISPR/Cas9 KO Plasmid (m) | sc-419086 | m | Gene Knockout | GFP | 0 | ||
12-LO HDR Plasmid (m) | sc-419086-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
12-LO Double Nickase Plasmid (m) | sc-419086-NIC | m | Gene Knockout | Puromycin | 0 | ||
12-LO Double Nickase Plasmid (m2) | sc-419086-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
15-LO CRISPR/Cas9 KO Plasmid (h2) | sc-401591-KO-2 | h | Gene Knockout | GFP | 1 | ||
15-LO HDR Plasmid (h2) | sc-401591-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
15-LO Double Nickase Plasmid (h) | sc-401591-NIC | h | Gene Knockout | Puromycin | 1 | ||
15-LO Double Nickase Plasmid (h2) | sc-401591-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
15-LO2 CRISPR/Cas9 KO Plasmid (h) | sc-404699 | h | Gene Knockout | GFP | 0 | ||
15-LO2 HDR Plasmid (h) | sc-404699-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
15-LO2 Double Nickase Plasmid (h) | sc-404699-NIC | h | Gene Knockout | Puromycin | 0 | ||
15-LO2 Double Nickase Plasmid (h2) | sc-404699-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
15-LO2 CRISPR/Cas9 KO Plasmid (m) | sc-419090 | m | Gene Knockout | GFP | 0 | ||
15-LO2 Double Nickase Plasmid (m) | sc-419090-NIC | m | Gene Knockout | Puromycin | 0 | ||
15-LO2 Double Nickase Plasmid (m2) | sc-419090-NIC-2 | m | Gene Knockout | Puromycin | 0 |
LO CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
5-LO CRISPR Activation Plasmid (h) | sc-401239-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
/%base_sku__display_name%/ CRISPR Activation Plasmid (h2) | sc-401239-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
5-LO Lentiviral Activation Particles (h) | sc-401239-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
5-LO Lentiviral Activation Particles (h2) | sc-401239-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
5-LO CRISPR Activation Plasmid (m) | sc-419091-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
5-LO CRISPR Activation Plasmid (m2) | sc-419091-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
5-LO Lentiviral Activation Particles (m) | sc-419091-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
5-LO Lentiviral Activation Particles (m2) | sc-419091-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
12-LO CRISPR Activation Plasmid (h) | sc-403010-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
12-LO CRISPR Activation Plasmid (h2) | sc-403010-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
12-LO Lentiviral Activation Particles (h) | sc-403010-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
12-LO Lentiviral Activation Particles (h2) | sc-403010-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
12-LO CRISPR Activation Plasmid (m) | sc-419086-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
12-LO CRISPR Activation Plasmid (m2) | sc-419086-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
12-LO Lentiviral Activation Particles (m) | sc-419086-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
12-LO Lentiviral Activation Particles (m2) | sc-419086-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
15-LO CRISPR Activation Plasmid (h) | sc-401591-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
15-LO CRISPR Activation Plasmid (h2) | sc-401591-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
15-LO Lentiviral Activation Particles (h) | sc-401591-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
15-LO Lentiviral Activation Particles (h2) | sc-401591-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
15-LO2 CRISPR Activation Plasmid (h) | sc-404699-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
15-LO2 CRISPR Activation Plasmid (h2) | sc-404699-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
15-LO2 Lentiviral Activation Particles (h) | sc-404699-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
15-LO2 Lentiviral Activation Particles (h2) | sc-404699-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
15-LO2 CRISPR Activation Plasmid (m) | sc-419090-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
15-LO2 CRISPR Activation Plasmid (m2) | sc-419090-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
15-LO2 Lentiviral Activation Particles (m) | sc-419090-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
15-LO2 Lentiviral Activation Particles (m2) | sc-419090-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
LO siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
5-LO siRNA (h) | sc-29596 | h | Gene Silencing | N/A | 7 | ||
5-LO shRNA Plasmid (h) | sc-29596-SH | h | Gene Silencing | Puromycin | 7 | ||
5-LO shRNA (h) Lentivirale Partikel | sc-29596-V | h | Gene Silencing | Puromycin | 7 | ||
5-LO siRNA (m) | sc-29597 | m | Gene Silencing | N/A | 3 | ||
5-LO shRNA Plasmid (m) | sc-29597-SH | m | Gene Silencing | Puromycin | 3 | ||
5-LO shRNA (m) Lentivirale Partikel | sc-29597-V | m | Gene Silencing | Puromycin | 3 | ||
12-LO siRNA (h) | sc-45984 | h | Gene Silencing | N/A | 1 | ||
12-LO shRNA Plasmid (h) | sc-45984-SH | h | Gene Silencing | Puromycin | 1 | ||
12-LO shRNA (h) Lentivirale Partikel | sc-45984-V | h | Gene Silencing | Puromycin | 1 | ||
12-LO siRNA (m) | sc-45985 | m | Gene Silencing | N/A | 1 | ||
12-LO shRNA Plasmid (m) | sc-45985-SH | m | Gene Silencing | Puromycin | 1 | ||
12-LO shRNA (m) Lentivirale Partikel | sc-45985-V | m | Gene Silencing | Puromycin | 1 | ||
15-LO siRNA (h) | sc-105003 | h | Gene Silencing | N/A | 2 | ||
15-LO shRNA Plasmid (h) | sc-105003-SH | h | Gene Silencing | Puromycin | 2 | ||
15-LO shRNA (h) Lentivirale Partikel | sc-105003-V | h | Gene Silencing | Puromycin | 2 | ||
15-LO2 siRNA (h) | sc-45626 | h | Gene Silencing | N/A | 0 | ||
15-LO2 shRNA Plasmid (h) | sc-45626-SH | h | Gene Silencing | Puromycin | 0 | ||
15-LO2 shRNA (h) Lentivirale Partikel | sc-45626-V | h | Gene Silencing | Puromycin | 0 | ||
15-LO2 siRNA (m) | sc-45627 | m | Gene Silencing | N/A | 1 | ||
15-LO2 shRNA Plasmid (m) | sc-45627-SH | m | Gene Silencing | Puromycin | 1 | ||
15-LO2 shRNA (m) Lentivirale Partikel | sc-45627-V | m | Gene Silencing | Puromycin | 1 |